Patent · US Active

Composition containing lignan compound as active ingredient for preventing or treating cancer

US9820963B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY · KR

Inventors

Sei Ryang Oh · Daejeon, KR
Yong Yeon Cho · Seojong-myeon, KR
Hyung Won RYU · Daejeon, KR
Cheol Jung Lee · Seojong-myeon, KR
Hye Suk LEE · Daejeon, KR
Doo Young Kim · Daejeon, KR
Jung Hee Kim · Daejeon, KR
Kyung Seop Ahn · Daejeon, KR
Mee Hyun Lee · Seojong-myeon, KR
Hyeong Kyu Lee · Daejeon, KR

Key dates

Filing date	Nov 8, 2013
Grant date	Nov 21, 2017
Priority date	—
Expiry date	Nov 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition.Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.